Bill Text: US HB3839 | 2023-2024 | 118th Congress | Introduced
Bill Title: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Sponsorship: Bipartisan Bill
Status: (Introduced - Dead) 2023-06-09 - Referred to the Subcommittee on Health. [HB3839 Detail]
Download: US_Congress-2023-HB3839-Introduced.pdf
